KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Current Deferred Revenue (2016 - 2026)

Silicon Laboratories has reported Current Deferred Revenue over the past 17 years, most recently at $5.4 million for Q1 2026.

  • Quarterly results put Current Deferred Revenue at $5.4 million for Q1 2026, up 74.39% from a year ago — trailing twelve months through Jan 2026 was $5.4 million (up 74.39% YoY), and the annual figure for FY2026 was $5.4 million, up 74.39%.
  • Current Deferred Revenue for Q1 2026 was $5.4 million at Silicon Laboratories, down from $8.4 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for SLAB hit a ceiling of $21.6 million in Q2 2022 and a floor of $2.1 million in Q4 2023.
  • Median Current Deferred Revenue over the past 5 years was $8.4 million (2025), compared with a mean of $8.4 million.
  • Biggest five-year swings in Current Deferred Revenue: plummeted 70.08% in 2024 and later skyrocketed 74.39% in 2026.
  • Silicon Laboratories' Current Deferred Revenue stood at $6.8 million in 2022, then plummeted by 68.78% to $2.1 million in 2023, then skyrocketed by 45.16% to $3.1 million in 2024, then surged by 174.88% to $8.4 million in 2025, then tumbled by 36.56% to $5.4 million in 2026.
  • The last three reported values for Current Deferred Revenue were $5.4 million (Q1 2026), $8.4 million (Q4 2025), and $3.9 million (Q3 2025) per Business Quant data.